Does Timing of Diagnosis and Management of Iatrogenic Ureter Injuries Affect Outcomes? Experience From a Tertiary Center.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
03 2021
Historique:
received: 29 08 2020
revised: 29 11 2020
accepted: 30 11 2020
pubmed: 15 12 2020
medline: 25 2 2022
entrez: 14 12 2020
Statut: ppublish

Résumé

To report urologic outcomes from a series of IUIs, sustained during nonurologic procedures, with regards to timing of diagnosis and management of the injury. Iatrogenic ureteral injury (IUI) is the most common mechanism of ureteral trauma. Injuries can be intraoperatively diagnosed (IOD) or postoperatively diagnosed (POD). This was a retrospective chart review of adult patients at a single institution who sustained an IUI from a non-urologic procedure between 2008 and 2019. Primary outcome was tube-dependence (ureter stent or nephrostomy tube) and nephrectomy rates at last follow-up. Secondary outcome was the number of additional urologic procedures required to manage subsequent complications of IUI. There were 30 patients with IOD and 57 patients with POD. In the IOD group, at mean follow up of 6.3 months, 4 patients (14.3%) were tube dependent. In the POD group, at mean follow up of 13.1 months, 5 patients (10%) were tube dependent (P = .570). Rate of nephrectomy was higher in POD group compared to IOD, but the difference was not statistically significant (12.3% vs 6% respectively, P = .414). Additionally, in the POD group, 56% and 19.3% required a secondary and tertiary procedure to manage IUI complications, respectively. These rates were 16.7% (P < .001) and 3.3% (P = .002) in the IOD group. Delayed diagnosis of IUI was significantly associated with increased number of procedures needed to manage the injury. The rate of nephrectomy and tube dependence in this group was higher but not statistically significant. Delayed diagnosis of IUI is associated with higher treatment burden.

Identifiants

pubmed: 33309708
pii: S0090-4295(20)31485-0
doi: 10.1016/j.urology.2020.11.052
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-244

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hal D Kominsky (HD)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Nayan C Shah (NC)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Nicholas J Beecroft (NJ)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Dinah Diab (D)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Iryna M Crescenze (IM)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Tasha Posid (T)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.

Nima Baradaran (N)

Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: nima.baradaran@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH